Sign in
4

Changes in Ownership

Benitec Biopharma Inc. Filed Acc 0000899140-25-001479

Director bought 144,223 shares at an average $13.20 ($1,903,133)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2025-12-23 Purchase +42,600 $12.85 $547,410 9,620,075 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2025-12-23 Purchase +7,400 $12.85 $95,090 1,834,053 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2025-12-26 Purchase +14,320 $13.10 $187,592 9,634,395 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2025-12-26 Purchase +2,516 $13.10 $32,960 1,836,569 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2025-12-29 Purchase +65,800 $13.44 $884,352 9,700,195 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2025-12-29 Purchase +11,587 $13.44 $155,729 1,848,156 I
Open-market purchases · 144,223 sh · avg $13.20 · $1,903,133
Loading xslF345X05/form4.xml…